U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials
The U.S. Senate last night passed the “Improving Access to Clinical Trials Act” (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.
Read more on News-Medical-Net
Popular Posts:
- Know the Truth about the Government Health Care Bill HR 3200-Key Points.flv
- House Passes Obama’s Healthcare Reform Bill
- Summary Box: Lilly halts Alzheimer’s drug
- Geron shares rise on stem cell study
- Geron shares rise on stem cell study